Citigroup’s Inspire Medical Systems INSP Stock Holding History
Bought
Maintained
Sold
Other funds holding INSP
Citigroup's INSP Position: Q3 2026 in Review
Citigroup reduced its Inspire Medical Systems (INSP) stake by 25% in Q3 2026, selling an estimated $1.16M and leaving 58,345 shares worth $4.05M. The position accounts for ﹤0.01% of the portfolio, ranked #2269.
Citigroup first reported a position in INSP in Q2 2018 and has held it in 34 quarters since. The position peaked at $6.69M in Q2 2025. 308 funds tracked by Wall St. Rank hold INSP as of Q3 2026.
- Citigroup held 58,345 shares of Inspire Medical Systems worth $4.05M as of Q3 2026.
- Citigroup sold 19,435 Inspire Medical Systems shares in Q3 2026, an estimated $1.16M.
- Inspire Medical Systems made up ﹤0.01% of Citigroup's portfolio in Q3 2026, its #2269 holding.
- Citigroup first reported a position in Inspire Medical Systems in Q2 2018 and has held it in 34 quarters since.
- Citigroup's Inspire Medical Systems position peaked at $6.69M in Q2 2025.
- 308 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q3 2026.
Based on Citigroup's 13F filing for Q3 2026, filed 4 Nov 2026.